USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/22199
Title: Persistent post-COVID 19 headache: results of a national survey
Authors: Nacu, Gabriela
Grosu, Oxana
Corcea, Galina
Odobescu, Stela
Moldovanu, Ion
Keywords: headache;post Covid-19;chronic
Issue Date: 2022
Publisher: Universitatea de Stat de Medicină şi Farmacie "Nicolae Testemiţanu" din Republica Moldova
Citation: NACU, Gabriela, GROSU, Oxana, CORCEA, Galina, et al. Persistent post-COVID 19 headache: results of a national survey: [poster]. In: Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 19-21 octombrie 2022: culegere de postere electronice. 2022, p. 129.
Abstract: Introduction. According to the National Institute for Health and Care Excellence (NICE), post-COVID-19 syndrome refers to a multisystemic affection with symptoms lasting more than 12 weeks after the onset of acute disease. Persistent headache, with a prevalence of 18%, seems to be the fifth most common symptom in patients with the so-called long COVID syndrome, which is characterized by “brain fog” with cognitive disturbances, fatigue, dyspnea, myalgia and muscle weakness, depression. The burden, characteristics, pathophysiology and management of long COVID headache are not completely understood. Purpose. To evaluate clinical phenotype of post-Covid 19 persistent headache in patients with acute headache history during the acute period of Covid 19 infection (study published in BAMS 2021). Material and methods This study is a survey. People, previously involved in the national survey of Headache in the context of the COVID 19 pandemic (conducted for 3 months in 2021), were asked to complete online a structured questionnaire. These patients had been tested serologically Covid 19 positive for the first time- more than 9 months ago. Results. From 140 people previously involved in the study "Headache in the context of COVID 19 pandemic - the results of a national survey", 89 patients completed the questionnaire about the persistence of post-Covid 19 headache, from which 30 people (33.7%) mentioned the persistence of headache after recovery. Mostly, we observed a moderate-severe intensity of the headache, which was localized in 33.3% (10p) in frontal region, with a predominantly oppressive character in 56.7% cases. In 60% cases, patients have experienced 1-2 times/week headache using in 5.3 ± 4.74 days/month (min 0.0; max 15.0) drug treatment. Conclusions. The headache is a disabling symptom of Covid 19 infection that persists even after recovery, it is clinically manifested by severe, moderate-severe pain affecting young women, a clinical feature Keywords highlighted in other previous studies.
metadata.dc.relation.ispartof: Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 2022
URI: https://conferinta.usmf.md/wp-content/uploads/culegere_de_postere_2022.pdf
http://repository.usmf.md/handle/20.500.12710/22199
Appears in Collections:Conferinţa ştiinţifică anuală "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță", 19-21 octombrie, 2022: Culegere de postere

Files in This Item:
File Description SizeFormat 
Persistent_post_COVID_19_headache_results_of_a_national_survey.pdf383.16 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback